Nuvation Bio

NUVBNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.298 B

$6.60 +8.02%

Close of 7 Aug 2026

Revenue

$62.9M

#2671 by revenue

Earnings

-$204.6M

Loss-making

Shares outstanding

351,123,233

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#98Bausch Health CompaniesBHC$2.34B
#99Sionna TherapeuticsSION$2.30B
#100Nuvation BioNUVB$2.30B
#101UroGen PharmaURGN$2.30B
#102Palvella TherapeuticsPVLA$2.27B

Where these numbers come from

Share counts and financials for Nuvation Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.